Effect of nodularin on the expression of glutathione S-transferase placental form and proliferating cell nuclear antigen in N-nitrosodiethylamine initiated hepatocarcinogenesis in the male Fischer 344 rat

Carcinogenesis

Volumn 20, Issue 8, 1999, Pages 1541-1548

  Song, Kye Yong ^a   Lim, In Kyoung ^b   Park, Sang Chul ^c   Lee, Seong Oh ^b   Park, Hyun Sook ^a   Choi, Yang Kyu ^d   Hyun, Byung Hwa ^d  

^a Chung Ang University College of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Seoul National University   (South Korea)

^d Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; DIETHYLNITROSAMINE; GLUTATHIONE TRANSFERASE; NODULARIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASOPHIL; CELL DEATH; CELL HYPERPLASIA; CELL PROLIFERATION; CONTROLLED STUDY; EOSINOPHIL; LIVER CARCINOGENESIS; LIVER CELL; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; CARCINOGENS; DIETHYLNITROSAMINE; GLUTATHIONE TRANSFERASE; HYPERPLASIA; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PEPTIDES, CYCLIC; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, INBRED F344;

EID: 0032873974     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.8.1541     Document Type: Article

References (39)

1. Stewart, H.L. (1975) Comparative aspects of certain cancers. In Becker, F.F. (ed.) Cancer. A Comprehensive Treatise. Plenum Press, New York, NY, Vol. 4. pp. 303-374.
2. Bannasch, P. and Zerban, H. (1997) Experimental chemical hepatocarcinogenesis. In Okuda, K. and Tabor, E. (eds) Liver Cancer. Churchill Livingstone, New York, NY, pp. 213-240.
3. Bannasch, P. (1996) Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular and metabolic changes. In Boyer, J.L. and Ockner, R.K. (eds) Progress in Liver Diseases. W.B. Saunders, Philadelphia, PA, pp. 161-197.
4. Bannasch, P. and Zerban, H. (1992) Predictive value of hepatic preneoplastic lesions as indicators of carcinogenic response. IRAC Sci. Publ., 116, 389-427.
5. Hasegawa, R. and Ito, N. (1994) Hepatocarcinogenesis in the rat. In Waalkes, M.P. and Ward, J.M. (eds) Carcinogens sis. Raven Press, New York, NY, pp. 39-65.
6. Bannasch, P. (1986) Preneoplastic lesions as end points in carcinogenicity testing. 1. Hepatic preneoplasia. Carcinogenesis, 7, 689-695.
7. Williams, G.M. (1989) The significance of chemically induced hepatocellular altered foci in rat liver and application to carcinogen detection. Toxicol. Pathol., 17, 663-672.
8. Pitot, H.C., Campbell, H.A., Maronpot, R., Bawa, R., Rizvi, T.A., Xu, Y.H., Sargent, L., Dragan, Y. and Pylon, M. (1989) Critical parameters in the quantitation of the stages of initiation, promotion and progression in one model of hepatocarcinogenesis in the rat. Toxicol. Pathol., 17, 594-612.
9. Ito, N., Tatematsu, M., Hasegawa, R. and Tsuda, H. (1989) Medium-term bioassay system for detection of carcinogens and modifiers of hepatocarcinogenesis utilizing the GST-P-positive liver cell focus as an endpoint marker. Toxicol. Pathol., 17, 630-641.
10. Ito, N., Shirai, T. and Hasegawa, R. (1992) Medium-term bioassays for carcinogens. MRC Sci. Publ., 116, 353-388.
11. Altmann, H.W. (1994) Hepatic neoformations. Pathol. Res. Pract., 190, 513-577.
12. Yu, S.Z. (1989) Drinking water and primary liver cancer. In Tang, Z.Y., Wu, M.C. and Xia, S.S. (eds) Primary Liver Cancer. Springer-Verlag, Berlin, Germany, pp. 30-37.
13. Lee, D.S., Huh, K., Lee, E.H., Lee, D.H., Hong, K.S. and Sung, Y.C. (1997) HCV and HBV coexist in HBs Ag-negative patients with HCV viraemia: possibility of coinfection in these patients must be considered in HBV-high endemic area. J. Gastroenterol. Hepatol., 12, 855-861.
14. Lee, H.S., Han, C.J. and Kim, C.Y. (1993) Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B-endemic area. Cancer, 72, 2564-2567.
15. Lee, H.S., Kim, S.T. and Kim, C.Y. (1990) Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinomas in Korea. J. Korean Med. Sci., 5, 145-148.
16. Park, B.C., Han, B.H., Ahn, S.Y., Lee, S.W., Lee, D.H., Lee, Y.N., Seo, J.H. and Kim, K.W. (1995) Prevalence of hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma in Korea. J. Viral Hepat., 2, 195-202.
17. Shin, H.R., Lee, C.U., Park, H.J., Seol, S.Y., Chung, J.M., Choi, H.C., Ahn, Y.O. and Shigemastu, T. (1996) Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan. Korean Int. J. Epidemiol., 25, 933-940.
18. Edamato, Y., Tani, M., Kurata, T. and Abe, K. (1996) Hepatitis C and B virus infections in hepatocellular carcinoma. Analysis of direct detection of viral genome in paraffin embedded tissues. Cancer, 77, 1787-1791.
19. Sato, A., Kato, Y., Nakata, K., Nakao, K., Daikoku, M., Ishii, N., Matsumoto, T., Iseki, K., Mazume, H. and Nagataki, S. (1996) Relationship between sustained elevation of serum alanine aminotransferase and progression from cirrhosis to hepatocellular carcinoma: comparison in patients with hepatitis B virus-and hepatitis C virus-associated cirrhosis. J. Gastroenterol. Hepatol., 11, 944-948.
20. Shiratori, Y., Shiina, S., Zhang, P.Y., Ohno, E., Okudaira, T., Payawal, D.A., Ono-Nita, S.K., Imamura, M., Kato, N. and Omata, M. (1997) Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan? Cancer, 80, 2060-2067.
21. Carmichael, W.W., Eschedor, J.T., Patterson, G.M. and Moore, R.E. (1988) Toxicity and partial structure of a hepatotoxic peptide produced by the cyanobacterium Nodularia spumigena Mertens emend. L575 from New Zealand. Appl. Environ. Microbiol., 54, 2757-2763.
22. Nishiwaki-Matsushima, R., Ohta, T., Nishiwaki, S., Suganuma, M., Kohyama, K., Ishikawa, T., Carmichael, W.W. and Fujiki, H. (1992) Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR. J. Cancer Res. Clin. Oncol., 118, 420-424.
23. Chen, D.Z., Boland, M.P., Smillie, M.A., Klix, H., Ptak, C., Andersen, R.J. and Holmes, C.F. (1993) Identification of protein phosphatase inhibitors of the microcystin class in the marine environment. Toxicology, 31, 1407-1414.
24. Harding, W.R., Rowe, N., Wessels, J.C., Beattie, K.A. and Codd, G.A. (1995) Death of a dog attributed to the cyanobacterial (blue-green algae) hepatotoxin nodularin in South Africa. J. S. Afr. Vet. Assoc., 66, 256-259.
25. Fujiki, H., Sueoka, E., Komori, A. and Suganuma, M. (1997) Tumor promotion and TNF-α gene expression by the okadaic acid class tumor promoters. Environ. Carcinog. Ecotoxicol. Rev., C15, 1-40.
26. Honkanen, R.E., Codispoti, B.A., Tse, K. and Boynton, A.L. (1994) Characterization of natural toxins with inhibitory activity against serine/ threonine protein phosphatases. Toxicology, 32, 339-350.
27. Honkanen, R.E., Dukelow, M., Zwiller, J., Moore, R.E., Khatra, B.S. and Boynton, A.L. (1991) Cyanobacterial nodularin is a potent inhibitor of type 1 and type 2A protein phosphatases. Mol. Pharmacol., 40, 577-583.
28. Sueoka, E., Sueoka, N., Okabe, S., Kozu, T., Komori, A., Ohta, T., Suganuma, M., Kim, S.-J., Lim, I.K. and Fujiki, H. (1997) Expression of the tumor necrosis factor a gene and early response genes by nodularin, a liver tumor promoter in primary cultured rat hepatocytes. J. Cancer Res. Clin. Oncol., 123, 413-419.
29. Ohta, T., Sueoka, E., Iida, N., Komori, A., Suganuma, M., Nishiwaki, R., Tatematus, M., Kim, S.-J., Carmichael, W.W. and Fujiki, H. (1994) Nodularin, a potent inhibitor of protein phosphatases 1 and 2A, is a new environmental carcinogen in male F344 rat liver. Cancer Res., 54, 6402-6406.
30. Soll, D.B. and Farber, E. (1976) New principle for the analysis of chemical carcinogenesis. Nature, 263, 702-703.
31. Ito, N., Tatematsu, M., Nakanishi, K., Hasegawa, R., Takano, T., Imaida, K. and Ogiso, T. (1980) The effects of various chemicals on the development of hyperplastic liver nodules in hepatectomized rats treated with N-nitrosodiethylamine or N-2-fluorenylacetamide. Gann, 71, 832-842.
32. Moore, M.R., Drinkwater, N.R., Miller, E.C., Miller, K.A. and Pitot, H.C. (1981) Quantitative analysis of the time-dependent development of glucose-6-phosphatase-deficient foci in the livers of mice treated neonatally with diethylnitrosamine. Cancer Res., 41, 1585-1593.
33. Kwak, S.-J. and Park, S.C. (1988) Purification and characterization of glutathione S-transferase p from human placental tissues. Seoul J. Med., 29, 107-118.
34. Lim, I.K., Hwang, D.S. and Kim, Y.S. (1982) A study of plasma membrane surface proteins of transformed rat liver cells induced by 3́-methyl-4-dimethyl-aminoazobenzene. Yonsei J. Med. Sci., 15, 108-124.
35. Prelich, G., Kostura, M., Marshak, D.R., Mathews, M.B. and Stillman, B. (1987) The cell-cycle regulated proliferating cell nuclear antigen is required for SV40 DNA replication in vitro. Nature, 326, 471-475.
36. Tan, C.K., Castillo, C., So, A.G. and Downey, K.M. (1986) An auxiliary protein for DNA polymerase-delta from fetal calf thymus. J. Biol. Chem., 261, 12310-12316.
37. Prelich, G. and Stillman, B. (1988) Coordinated leading and lagging strand synthesis during SV40 DNA replication in vitro requires PCNA. Cell, 53, 117-126.
38. Tsurimoto, T., Melendy, T. and Stillman, B. (1990) Sequential initiation of lagging and leading strand synthesis by two different polymerase complexes at the SV40 DNA replication origin. Nature, 346, 534-539.
39. Waga, S. and Stillman, B. (1994) Anatomy of a DNA replication fork revealed by reconstitution of SV40 DNA replication in vitro. Nature, 369, 207-212.